Patient Anxiety About Prostate Cancer Independently Predicts Early Initiation of Androgen Deprivation Therapy for Biochemical Cancer Recurrence in Older Men: A Prospective Cohort Study

PURPOSE: Androgen deprivation therapy (ADT) is first-line therapy for patients with prostate cancer (PCA) who experience biochemical recurrence (BCR). However, the optimal timing of ADT initiation is uncertain, and earlier ADT initiation can cause toxicities that lower quality of life (QOL). We test...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Dale, William, Hemmerich, Joshua, Bylow, Kathryn, Mohile, Supriya, Mullaney, Mary, Stadler, Walter M.
Format: Artigo
Langue:Inglês
Publié: American Society of Clinical Oncology 2009
Sujets:
Original Reports
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2738613/
https://ncbi.nlm.nih.gov/pubmed/19255325
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2008.18.5850
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires